Clinical Trial Update: Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating erlotinib, paclitaxel, and carboplatin with radiation therapy for stage III non-small cell lung cancer has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• ERLOTINIB (Erlotinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Nathan Pennell, MD, PhD | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-20